Verition Fund Management
CME icon

Verition Fund Management’s CME Group CME Stock Holding History

Verition Fund Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.43M Buy
18,400
+7,800
+74% +$2.32M 0.04% 544
2025
Q4 		$2.89M Sell
10,600
-24,200
-70% -$6.58M 0.01% 1283
2025
Q3 		$9.4M Buy
34,800
+5,800
+20% +$1.58M 0.04% 561
2025
Q2 		$7.99M Buy
29,000
+11,800
+69% +$3.21M 0.04% 674
2025
Q1 		$4.56M Buy
17,200
+3,400
+25% +$839K 0.02% 905
2024
Q4 		$3.2M Sell
13,800
-1,800
-12% -$414K 0.01% 1215
2024
Q3 		$3.44M Hold
15,600
– – 0.02% 1091
2024
Q2 		$3.07M Buy
15,600
+4,900
+46% +$1.01M 0.02% 1030
2024
Q1 		$2.3M Buy
10,700
+9,000
+529% +$1.89M 0.02% 1133
2023
Q4 		$358K Buy
+1,700
New +$363K ﹤0.01% 1695
2022
Q4 		– Sell
-3,400
Closed -$602K – 2229
2022
Q3 		$602K Buy
+3,400
New +$672K 0.01% 1761
2022
Q2 		– Sell
-6,600
Closed -$1.57M – 2442
2022
Q1 		$1.57M Hold
6,600
– – 0.02% 1142
2021
Q4 		$1.51M Buy
+6,600
New +$1.45M 0.01% 1045

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Verition Fund Management's CME Position: Q1 2026 in Review

Verition Fund Management reduced its CME Group (CME) stake by 95% in Q1 2026, selling an estimated $4.7M and leaving 872 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

Verition Fund Management first reported a position in CME in Q2 2013 and has held it in 36 quarters since. The position peaked at $25.6M in Q1 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Verition Fund Management held 872 shares of CME Group worth $258K as of Q1 2026.
  • Verition Fund Management sold 15,824 CME Group shares in Q1 2026, an estimated $4.7M.
  • CME Group made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1847 holding.
  • Verition Fund Management first reported a position in CME Group in Q2 2013 and has held it in 36 quarters since.
  • Verition Fund Management's CME Group position peaked at $25.6M in Q1 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.